Evidence map›Paper›PMID 33441704›Full record

ArticleScientific reports2021

Propofol infusions using a human target controlled infusion (TCI) pump in chimpanzees (Pan troglodytes).

T Miyabe-Nishiwaki, A Kaneko, A Yamanaka, N Maeda, J Suzuki, M Tomonaga, T Matsuzawa, K Muta, R Nishimura, I Yajima and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

T Miyabe-NishiwakiPrimate Research Institute, Kyoto University, Inuyama, Aichi, Japan. miyabe.takako.2s@kyoto-u.ac.jp.
A KanekoPrimate Research Institute, Kyoto University, Inuyama, Aichi, Japan.
A YamanakaPrimate Research Institute, Kyoto University, Inuyama, Aichi, Japan.
N MaedaPrimate Research Institute, Kyoto University, Inuyama, Aichi, Japan.
J SuzukiPrimate Research Institute, Kyoto University, Inuyama, Aichi, Japan.
M TomonagaPrimate Research Institute, Kyoto University, Inuyama, Aichi, Japan.
T MatsuzawaChubu Gakuin University, Seki, Gifu, Japan.
K MutaLaboratory of Veterinary Surgery, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
R NishimuraLaboratory of Veterinary Surgery, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
I YajimaDepartment of Pharmacy, National Defense Medical College Hospital, Tokorozawa, Saitama, Japan.
D J EleveldUniversity Medical Center Groningen, Groningen, Netherlands.
A R AbsalomUniversity Medical Center Groningen, Groningen, Netherlands.
K MasuiDepartment of Anesthesiology, Showa University School of Medicine, Shinagawa-ku, Tokyo, Japan. kenichi@masuinet.com.
Kyoto University · JPThe University of Tokyo · JPUniversity Medical Center Groningen · NLChubu Gakuin University · JPNational Defense Medical College Hospital · JPShowa University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chimpanzees are genetically and physiologically similar to humans. Several pharmacokinetic models of propofol are available and target controlled infusion (TCI) of propofol is established in humans, but not in chimpanzees. The purpose of this study was to investigate if human pharmacokinetic models can accurately predict propofol plasma concentration (Cp) in chimpanzees and if it is feasible to perform TCI in chimpanzees. Ten chimpanzees were anaesthetized for regular veterinary examinations. Propofol was used as an induction or maintenance agent. Blood samples were collected from a catheter in a cephalic vein at 3-7 time points between 1 and 100 min following the propofol bolus and/or infusion in five chimpanzees, or TCI in six chimpanzees. Cp was measured using high-performance liquid chromatography. The Marsh, Schnider and Eleveld human pharmacokinetic models were used to predict Cp for each case and we examined the predictive performances of these models using the Varvel criteria Median PE and Median APE. Median PE and Median APE for Marsh, Schnider and Eleveld models were within or close to the acceptable range. A human TCI pump was successfully maintained propofol Cp during general anesthesia in six chimpanzees. Human propofol pharmacokinetic models and TCI pumps can be applied in chimpanzees.

Indexed as

Anesthesia, GeneralAnesthesia, IntravenousAnesthetics, IntravenousAnimalsFemaleHumansInfusion PumpsInfusions, IntravenousMaleModels, BiologicalPan troglodytesPropofolAnesthetics, IntravenousPropofol

Identifiers

PMID33441704
PMCPMC7806914
OpenAlexW3120723610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.